N@N

Healthnostics Reports 40% Revenue Growth Rate in GMD

^{Published on 2008-12-04 07:32:13 - Market Wire}
 

NEW YORK--([ BUSINESS WIRE ])--Healthnostics, Inc. (OTC:HNSO), a medical and biotechnology information and technology company, reported that GMD, Inc. ("GMD") is on track to achieve a 40% growth in revenue on a profitable basis for its 2009 fiscal year, which began July 1, 2008. Monthly revenue for Fiscal Year 2009 is averaging nearly $1.2 million compared with $830,000 for Fiscal Year 2008.

Alan Grofé, President of Healthnostics and CEO of GMD, Inc., commented, "We look forward to reporting successive strong sales and revenue growth for GMD because it maintains a strong position in the recession-resistant diabetic supply market."

About GMD, Inc.

Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients lead healthier and more productive lives. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetes maintenance medications, diabetic shoes and orthopedic inserts.

For further information please visit Healthnostics [ www.healthnostics.com ], MedBioWorld [ www.medbioworld.com ], MedNets [ www.mednets.com ], and FamilyMedicalNet [ www.familymedicalnet.com ].

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.